Upgrade to SI Premium - Free Trial

Quest Diagnostics (DGX) PT Raised to $245 at BofA Securities

April 22, 2026 4:14 AM
BofA Securities analyst Derik de Bruin raised the price target on Quest Diagnostics (NYSE: DGX) to $245.00 (from $225.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change